State of Wisconsin Investment Board’s Trillium Therapeutics Inc. TRIL Stock Holding History

State of Wisconsin Investment Board’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-126,500	Closed	-$2.22M	–	2282
2021 Q3	$2.22M	Buy	126,500 +1,758	+1%	+$20.5K	﹤0.01%	1257
2021 Q2	$1.21M	Buy	+124,742	New	+$1.17M	﹤0.01%	1399

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

State of Wisconsin Investment Board's TRIL Position: Q4 2021 in Review

State of Wisconsin Investment Board sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 126,500 shares — an estimated $2.22M sold.

State of Wisconsin Investment Board first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $2.22M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

State of Wisconsin Investment Board reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 126,500 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $2.22M.
State of Wisconsin Investment Board first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
State of Wisconsin Investment Board's Trillium Therapeutics Inc. position peaked at $2.22M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2021, filed 11 Feb 2022.